News & Updates
Filter by Specialty:
Novel intravaginal device for postpartum bleeding passes muster in phase II trial
A less invasive intravaginal device that facilitates bimanual uterine compression appears to work well in the treatment of postpartum haemorrhage, according to the results of a phase II trial.
Novel intravaginal device for postpartum bleeding passes muster in phase II trial
09 Mar 2023COVID-19 infection in early pregnancy ups risk of stillbirth
Pregnant women who contract COVID-19 during early and mid-pregnancy are at risk of stillbirth, but this risk may not be present when infection occurs at any time during the third trimester or before delivery, as reported in a study.
COVID-19 infection in early pregnancy ups risk of stillbirth
08 Mar 2023Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS
In the treatment of polycystic ovary syndrome (PCOS), the combination of metformin plus oral contraceptives appears to benefit women without obesity, inducing favourable effects on glucose metabolism with no further harm on lipid metabolism, according to the results of a meta-analysis.
Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS
07 Mar 2023Insulin resistance, fertility outcomes favour carnitine in PCOS
Carnitine appears to be beneficial in the treatment of women with polycystic ovary syndrome (PCOS), with the drug helping improve ovulation, clinical pregnancy, insulin resistance, and body mass index, according to the results of a meta-analysis.
Insulin resistance, fertility outcomes favour carnitine in PCOS
05 Mar 2023HPV infection ups CVD risk, but not in vaccinated women
Human papillomavirus (HPV) infection appears to be a risk factor for cardiovascular diseases (CVDs), suggests a recent study. However, women vaccinated against HPV are protected against such risk.
HPV infection ups CVD risk, but not in vaccinated women
02 Mar 2023Obesity, metabolic dysfunction linked to BPE in premenopausal women
A recent study has established the association of increased background parenchymal enhancement (BPE) with obesity, insulin resistance, leptin, and adiponectin in premenopausal women who are at high risk of breast cancer.